D
Day One Biopharmaceuticals Inc
NASDAQ:DAWN
Day One Biopharmaceuticals Inc
NASDAQ:DAWN
Price:
11.8
USD
-2.24%
Market Closed
Market Cap:
$1.2B
Relative Value
The Relative Value of one DAWN stock under the Base Case scenario is hidden USD. Compared to the current market price of 11.8 USD, Day One Biopharmaceuticals Inc is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
DAWN Relative Value
HIDDEN
Multiples Across Competitors
DAWN Competitors Multiples
Day One Biopharmaceuticals Inc Competitors
Day One Biopharmaceuticals Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
D
|
Day One Biopharmaceuticals Inc
NASDAQ:DAWN
|
1.2B USD | 9.1 | -8 | -4.7 | -4.6 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
399.2B USD | 6.7 | 170 | 16.5 | 23.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
202.4B USD | 5.5 | 26.2 | 15 | 15 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
188.1B USD | 6.4 | 22.1 | 15 | 15 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
121B USD | 10.1 | 30.6 | 23.4 | 24.4 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.1B USD | 5.7 | 18.3 | 13.8 | 15.8 | |
| AU |
|
CSL Ltd
ASX:CSL
|
74.2B AUD | 3.3 | 17.2 | 11.7 | 14.7 | |
| NL |
|
argenx SE
XBRU:ARGX
|
44.2B EUR | 14.2 | 33.5 | 57.5 | 59.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
